We care for your eye health
Since 2012, we have been working to improve eye health with a focus on excellence and proximity.
We want to be relevant
Brill seeks to improve people’s quality of life through differentiation and innovation based on honesty and transparency in its relationship with patients and healthcare professionals.
Innovation
Active listening
Growth
Our journey: Milestones and evolution
Our journey:
Milestones and evolution

2012
Brill is founded with the mission of innovating in eye health care
2017
Brill reaches a team of 100 employees, consolidating its growth in the domestic market.
2018
Registration of Iluvien
Brill Pharma signs an exclusive agreement for the distribution of ILUVIEN® in Spain.
2018
Start of international expansion: Brill arrives in Portugal.
2019
Creation of Brill International, responsible for leading the Brill Group’s global expansion strategy.
2019
Brill Engines is founded, a unit dedicated to research, development and innovation, as well as the manufacture of in-house solutions.
2023
Brill establishes itself in Malaysia, marking its entry into the Asian market.
2023
Launch of the Brill Corneal Esthesiometer.
2024
Establishment of Brill USA as part of the expansion strategy in the Americas.

Brill is founded with the mission of innovating in eye health care
Brill reaches a team of 100 employees, consolidating its growth in the domestic market.
Registration of Iluvien
Brill Pharma signs an exclusivity agreement for the distribution of ILUVIEN® in Spain.
Start of international expansion: Brill arrives in Portugal.
Creation of Brill International, responsible for leading the Brill Group’s global expansion strategy.
Brill Engines is founded, a unit dedicated to research, development and innovation, as well as the manufacture of in-house solutions.
Brill establishes itself in Malaysia, marking its entry into the Asian market.
Launch of the Brill Corneal Esthesiometer.
Establishment of Brill USA as part of the expansion strategy in the Americas.
Brill in figures
Financial data
Growth of 37%
15% FCT
+50
Internationalization
+200
Presence in
Brill in figures
Financial data
Growth of 37%
15% FCT
+50
Internationalization
+200
Presence in
Brill in figures
Financial data
37%
x2
10% FCT
+ 50
Brill in figures
Financial data